About this role
Driving strategic transactions across the life sciences and biotech sectors involves sourcing and executing acquisitions, investments, and partnerships while partnering directly with leadership, research, and product teams. Frontier AI is beginning to transform how drugs are discovered and brought to patients, creating a need for dedicated corporate development leadership to shape organizational strategy in the sector. Success in this position requires a combination of deep life sciences domain knowledge, technical fluency in artificial intelligence, and a track record of closing complex business transactions.
Professionals in this function evaluate target companies by assessing underlying science, data, and compliance posture alongside standard financial metrics. Candidates should understand research and development, clinical workflows, and regulatory pathways while maintaining a strong commitment to AI safety and organizational mission. This position operates at the intersection of advanced technology and medicine, offering direct impact on corporate growth within a rapidly evolving field.
What you will do
- Define and execute corporate development strategy in life sciences, covering acquihires, tuck-in acquisitions, minority investments, and strategic partnerships.
- Build and maintain a target pipeline across AI-native companies in drug discovery, clinical development, regulatory writing, lab automation, and healthcare data infrastructure.
- Lead end-to-end transaction processes from sourcing through diligence, negotiation, signing, and integration.
- Partner with research, product, engineering, and go-to-market teams to assess technical, scientific, and commercial value.
- Run sector-specific diligence including scientific and data validation, regulatory posture, data privacy, quality systems, and intellectual property.
- Structure and negotiate complex deals such as earnouts, milestone-based consideration, and licensing arrangements with legal, finance, and policy teams.
- Build financial models and valuation analyses tailored to life sciences businesses including services-heavy and usage-based revenue models.
What you need
- Have led complex M&A, investment, or partnership transactions from sourcing through close.
- Understand the drug development lifecycle from discovery through clinical trials, regulatory submission, and commercialization.
- Have strong technical fluency in AI and software gained as an engineer, product manager, scientist, or technology investor.
- Bring strong analytical and financial modeling skills.
- Can engage credibly with scientists, engineers, executives, and regulators.
- Are comfortable in fast-paced, ambiguous environments with competing priorities.
- Write and speak clearly while maintaining the ability to influence at all levels.
Nice to have
- Have 8-12 years of experience across corporate development, investment banking, or investing with at least 5 years focused on life sciences, biotech, or healthcare technology
- Hold an advanced degree in the life sciences such as a PhD, MD, PharmD, or an MBA
- Have worked at a pharmaceutical company, biotech, CRO, or life sciences software company
- Have experience with AI/ML applied to biology, chemistry, or clinical operations
- Bring an established network among life sciences founders, healthcare VCs, and pharma business development leaders
Skills and tech stack
Questions candidates ask
What is the remote work policy for this role?
Staff are expected to be in one of the offices at least 25% of the time, though some roles may require more frequent in-office presence.
What is the compensation range for this position?
The annual base salary range for this role is between $425,000 and $600,000 USD.
Does the company provide visa sponsorship?
Yes, visa sponsorship is available, and an immigration lawyer is retained to assist successful candidates with the visa process.